ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Fundamental Analysis & Valuation

NASDAQ:ZBRA • US9892071054

Current stock price

203.97 USD
+1.25 (+0.62%)
At close:
204.59 USD
+0.62 (+0.3%)
After Hours:

This ZBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ZBRA Profitability Analysis

1.1 Basic Checks

  • In the past year ZBRA was profitable.
  • ZBRA had a positive operating cash flow in the past year.
  • Each year in the past 5 years ZBRA has been profitable.
  • Of the past 5 years ZBRA 4 years had a positive operating cash flow.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

  • ZBRA's Return On Assets of 4.93% is fine compared to the rest of the industry. ZBRA outperforms 70.16% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.68%, ZBRA is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
  • ZBRA's Return On Invested Capital of 9.50% is amongst the best of the industry. ZBRA outperforms 80.65% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ZBRA is in line with the industry average of 8.63%.
  • The 3 year average ROIC (9.08%) for ZBRA is below the current ROIC(9.50%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROIC 9.5%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • ZBRA's Profit Margin of 7.77% is fine compared to the rest of the industry. ZBRA outperforms 76.61% of its industry peers.
  • ZBRA's Profit Margin has declined in the last couple of years.
  • ZBRA's Operating Margin of 14.83% is amongst the best of the industry. ZBRA outperforms 86.29% of its industry peers.
  • In the last couple of years the Operating Margin of ZBRA has remained more or less at the same level.
  • ZBRA has a better Gross Margin (48.05%) than 82.26% of its industry peers.
  • ZBRA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ZBRA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZBRA is creating some value.
  • The number of shares outstanding for ZBRA has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ZBRA has less shares outstanding
  • Compared to 1 year ago, ZBRA has a worse debt to assets ratio.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • ZBRA has an Altman-Z score of 3.03. This indicates that ZBRA is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.03, ZBRA is in line with its industry, outperforming 45.97% of the companies in the same industry.
  • ZBRA has a debt to FCF ratio of 3.01. This is a good value and a sign of high solvency as ZBRA would need 3.01 years to pay back of all of its debts.
  • ZBRA has a better Debt to FCF ratio (3.01) than 71.77% of its industry peers.
  • ZBRA has a Debt/Equity ratio of 0.66. This is a neutral value indicating ZBRA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ZBRA (0.66) is worse than 82.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Altman-Z 3.03
ROIC/WACC1.06
WACC8.98%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • ZBRA has a Current Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.97, ZBRA is doing worse than 91.94% of the companies in the same industry.
  • ZBRA has a Quick Ratio of 0.97. This is a bad value and indicates that ZBRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.58, ZBRA is doing worse than 91.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.58
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ZBRA Growth Analysis

3.1 Past

  • ZBRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.25%, which is quite good.
  • The Earnings Per Share has been growing slightly by 4.34% on average over the past years.
  • Looking at the last year, ZBRA shows a quite strong growth in Revenue. The Revenue has grown by 8.33% in the last year.
  • ZBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.94% yearly.
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%

3.2 Future

  • Based on estimates for the next years, ZBRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.22% on average per year.
  • The Revenue is expected to grow by 7.44% on average over the next years.
EPS Next Y14.52%
EPS Next 2Y13.55%
EPS Next 3Y13.11%
EPS Next 5Y15.22%
Revenue Next Year11.43%
Revenue Next 2Y8.45%
Revenue Next 3Y7.6%
Revenue Next 5Y7.44%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

8

4. ZBRA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 12.88 indicates a correct valuation of ZBRA.
  • Based on the Price/Earnings ratio, ZBRA is valued cheaply inside the industry as 87.90% of the companies are valued more expensively.
  • ZBRA is valuated cheaply when we compare the Price/Earnings ratio to 25.96, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 11.24, the valuation of ZBRA can be described as very reasonable.
  • Based on the Price/Forward Earnings ratio, ZBRA is valued cheaply inside the industry as 85.48% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, ZBRA is valued rather cheaply.
Industry RankSector Rank
PE 12.88
Fwd PE 11.24
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZBRA is valued a bit cheaper than the industry average as 76.61% of the companies are valued more expensively.
  • 88.71% of the companies in the same industry are more expensive than ZBRA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.07
EV/EBITDA 12.6
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

  • ZBRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ZBRA may justify a higher PE ratio.
  • ZBRA's earnings are expected to grow with 13.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)2.97
EPS Next 2Y13.55%
EPS Next 3Y13.11%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZBRA Dividend Analysis

5.1 Amount

  • ZBRA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZBRA Fundamentals: All Metrics, Ratios and Statistics

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (3/16/2026, 8:02:00 PM)

After market: 204.59 +0.62 (+0.3%)

203.97

+1.25 (+0.62%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12
Earnings (Next)05-12
Inst Owners98.81%
Inst Owner Change-1.34%
Ins Owners0.77%
Ins Owner Change4.51%
Market Cap10.03B
Revenue(TTM)5.40B
Net Income(TTM)419.00M
Analysts79.23
Price Target343.86 (68.58%)
Short Float %4.17%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.28%
Min EPS beat(2)-1.97%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)3.72%
Min EPS beat(4)-1.97%
Max EPS beat(4)8.97%
EPS beat(8)6
Avg EPS beat(8)5.62%
EPS beat(12)8
Avg EPS beat(12)3.99%
EPS beat(16)11
Avg EPS beat(16)2.96%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.49%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.17%
Revenue beat(16)6
Avg Revenue beat(16)-1.21%
PT rev (1m)0.14%
PT rev (3m)-6.03%
EPS NQ rev (1m)3.01%
EPS NQ rev (3m)3.1%
EPS NY rev (1m)1.57%
EPS NY rev (3m)1.23%
Revenue NQ rev (1m)2.58%
Revenue NQ rev (3m)2.58%
Revenue NY rev (1m)1.53%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE 12.88
Fwd PE 11.24
P/S 1.86
P/FCF 12.07
P/OCF 10.94
P/B 2.8
P/tB N/A
EV/EBITDA 12.6
EPS(TTM)15.84
EY7.77%
EPS(NY)18.14
Fwd EY8.89%
FCF(TTM)16.89
FCFY8.28%
OCF(TTM)18.64
OCFY9.14%
SpS109.7
BVpS72.94
TBVpS-39.6
PEG (NY)0.89
PEG (5Y)2.97
Graham Number161.23
Profitability
Industry RankSector Rank
ROA 4.93%
ROE 11.68%
ROCE 12.03%
ROIC 9.5%
ROICexc 9.68%
ROICexgc 63.89%
OM 14.83%
PM (TTM) 7.77%
GM 48.05%
FCFM 15.4%
ROA(3y)5.2%
ROA(5y)7.04%
ROE(3y)12.05%
ROE(5y)16.23%
ROIC(3y)9.08%
ROIC(5y)11.91%
ROICexc(3y)9.75%
ROICexc(5y)12.66%
ROICexgc(3y)53.88%
ROICexgc(5y)104.36%
ROCE(3y)11.5%
ROCE(5y)15.08%
ROICexgc growth 3Y-21.35%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.63%
ROICexc growth 5Y-9.69%
OM growth 3Y-2.89%
OM growth 5Y-0.76%
PM growth 3Y-1.03%
PM growth 5Y-7.28%
GM growth 3Y1.92%
GM growth 5Y1.31%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 3.01
Debt/EBITDA 2.4
Cap/Depr 46.49%
Cap/Sales 1.59%
Interest Coverage 6.2
Cash Conversion 93.1%
Profit Quality 198.33%
Current Ratio 0.97
Quick Ratio 0.58
Altman-Z 3.03
F-Score5
WACC8.98%
ROIC/WACC1.06
Cap/Depr(3y)43.41%
Cap/Depr(5y)39.71%
Cap/Sales(3y)1.56%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
EPS Next Y14.52%
EPS Next 2Y13.55%
EPS Next 3Y13.11%
EPS Next 5Y15.22%
Revenue 1Y (TTM)8.33%
Revenue growth 3Y-2.27%
Revenue growth 5Y3.94%
Sales Q2Q%9.22%
Revenue Next Year11.43%
Revenue Next 2Y8.45%
Revenue Next 3Y7.6%
Revenue Next 5Y7.44%
EBIT growth 1Y4.58%
EBIT growth 3Y-5.1%
EBIT growth 5Y3.15%
EBIT Next Year26.94%
EBIT Next 3Y14.04%
EBIT Next 5Y11.74%
FCF growth 1Y-12.89%
FCF growth 3Y26.25%
FCF growth 5Y-1.47%
OCF growth 1Y-9.48%
OCF growth 3Y23.4%
OCF growth 5Y-0.95%

ZEBRA TECHNOLOGIES CORP-CL A / ZBRA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a fundamental rating of 5 / 10 to ZBRA.


Can you provide the valuation status for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a valuation rating of 8 / 10 to ZEBRA TECHNOLOGIES CORP-CL A (ZBRA). This can be considered as Undervalued.


How profitable is ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) stock?

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) has a profitability rating of 7 / 10.


How financially healthy is ZEBRA TECHNOLOGIES CORP-CL A?

The financial health rating of ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) is 4 / 10.